News Releases

2008 RSS

  • October 01, 2008

    Basic agreement reached with Nippon Shinyaku for the collaborative development and marketing of a new antipruritic agent (code NS-141)

  • October 01, 2008

    Domestic manufacture of downsized Uzel (calcium folinate) 25 mg tablets to be started soon

  • October 01, 2008

    Autumn 2008 version TV commercial for Tiovita Drink is aired

  • September 30, 2008

    Zosyn, a new injectable combination antibiotic of beta-lactamase inhibitor and penicillin domestically launched on October 1

  • September 30, 2008

    Taiho Pharmaceutical collaborates with and supports the Japan Pink Ribbon Campaign for this year

  • September 29, 2008

    46th fiscal-year (07/2007- 06/2008) report is released

  • September 22, 2008

    New website contents to promote medical check-ups for breast cancer are released

  • September 02, 2008

    The antipsoriatic ethical drugs, Urepearl-Plus Lotion 10 and Urepearl-Plus Cream are launched on September 3

  • August 20, 2008

    8th Oncology Media Seminar is held: Main topic - Current therapyfor breast cancer

  • July 25, 2008

    Notice: Three Otsuka group companies (Otsuka Pharmaceutical Factory, Otsuka Warehouse, and Taiho Pharmaceutical) are reorganized as wholly-owned direct subsidiaries

  • July 18, 2008

    License agreement with Sanofi-Aventis on TS-1 is terminated

  • July 18, 2008

    Results of a randomized comparative phase 3 study of
    S-1 in advanced/recurrent gastric cancer become available

  • July 16, 2008

    Notice: Acquisition of production/distribution license for Zosyn, a new injectable combination antibiotic of beta-lactamase inhibitor and penicillin

  • June 24, 2008

    Summer 2008 version TV commercial for Tiovita Drink is aired

  • April 07, 2008

    7th Oncology Media Seminar is opened: Main topic - Gastric cancer: Clinical studies of oral anti-gastric cancer agents and guidelines for the treatment of gastric cancer

  • March 25, 2008

    Results of a randomized comparative study of S-1 monotherapy compared to S-1 with cisplatin (SPIRITS trial) in advanced/recurrent gastric cancer is published in Lancet Oncology: New standard therapy for advanced gastric cancer anticipated

  • January 18, 2008

    Spring 2008 version TV commercial for Tiovita Drink is aired